Chronic obstructive pulmonary disease
GPTKB entity
Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
|
| gptkbp:abbreviation |
gptkb:COPD
|
| gptkbp:affects |
lungs
|
| gptkbp:burden |
significant healthcare cost
|
| gptkbp:cause |
aerosol
long-term exposure to irritating gases |
| gptkbp:complication |
gptkb:pneumonia
heart failure respiratory failure pulmonary hypertension |
| gptkbp:diagnosedBy |
spirometry
|
| gptkbp:firstDescribed |
19th century
|
| gptkbp:guidanceSystem |
gptkb:GOLD_guidelines
|
| gptkbp:hasEpidemiology |
affects millions worldwide
|
| gptkbp:hasQualityOfLifeImpact |
impairs daily activities
increases risk of depression reduces exercise tolerance |
| https://www.w3.org/2000/01/rdf-schema#label |
Chronic obstructive pulmonary disease
|
| gptkbp:ICD-10_code |
gptkb:J44
|
| gptkbp:managedBy |
pulmonologist
|
| gptkbp:mortalityRate |
high
|
| gptkbp:prevalence |
common in older adults
more common in men leading cause of death worldwide |
| gptkbp:prevention |
smoking cessation
reducing air pollution exposure |
| gptkbp:progression |
progressive
irreversible |
| gptkbp:relatedTo |
gptkb:alpha-1_antitrypsin_deficiency
asthma |
| gptkbp:riskFactor |
gptkb:air_pollution
genetic factors smoking occupational dust |
| gptkbp:signature |
cyanosis
wheezing barrel chest use of accessory muscles |
| gptkbp:subspecies |
chronic bronchitis
emphysema |
| gptkbp:symptom |
shortness of breath
chronic cough sputum production |
| gptkbp:treatment |
oxygen therapy
bronchodilators inhaled corticosteroids pulmonary rehabilitation |
| gptkbp:bfsParent |
gptkb:The_Lung
gptkb:Dyspnea |
| gptkbp:bfsLayer |
6
|